TRHR and columnar cell hyperplasia of the breast: In two previously reported children with biallelic TRHR mutations, associated clinical manifestations were mild (growth retardation, delayed bone age) despite biochemical evidence of CCH, with T4 levels ranging from 40 to 88% of the lower limit of normal.